The Qualcomm Foundation has awarded a three-year, $3.75 million grant to San Diego’s Scripps Health and its Scripps Translational Science Institute (STSI) to help advance the development of diagnostic tests, wireless devices, sensors, and other digital health technologies.
In a statement today, the institute says the funding is intended to support the kind of clinical trials needed to validate innovative technologies. The statement quotes Scripps CEO Chris Van Gorder as saying, “The generous grant from the Qualcomm Foundation reinforces our efforts to translate innovative discoveries into transformative clinical therapies.”
In this respect, STSI appears to be taking on a crucial role in technology commercialization that was intended to be a key part of the mission at San Diego’s West Wireless Health Institute. The West Wireless Health Institute, established in 2009 with Scripps Health as a founding health care affiliate and Qualcomm as a founding sponsor, announced plans that same year to conduct a clinical trial of wireless heart monitoring technology developed by San Jose, CA-based Corventis.
Eric Topol, director of STSI and chief academic officer for Scripps Health, underscored the importance of validating new wireless health technologies in a 2009 interview with CNBC about the West Wireless Health Institute. Topol also was an instrumental figure in founding the West Wireless Health Institute, and he served as the board’s vice-chairman and chief innovation officer.
But the wireless health institute—now known simply as the West Health Institute—changed course, and a West spokeswoman confirmed today that Topol officially stepped down … Next Page »